Cisplatin radiation head and neck
Web1990PMID 2224782— "Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17." (Marcial VA et al. Cancer. 1990 Nov 1;66(9):1861-8.) Outcome: 4-year LRC 43%, OS 34%. LRC and OS better in non … WebCisplatin, Radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage 1B cervical carcinoma. Keys HM et al. N Engl J Med (1999); 340: 1154 ... weekly cisplatin for locally advanced head and neck cancer. Head Neck 2005;27:36-43. 8. Medina JA, Rueda A, de Pasos AS, et al. A phase II study of …
Cisplatin radiation head and neck
Did you know?
WebPurpose: Although commonly used for the treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) concomitant radio-chemotherapy (RT-CT) with … WebSep 3, 1991 · After a preliminary dose-finding study involving 12 patients with advanced or locally recurrent head and neck cancer, 27 patients were treated on a phase II protocol, …
WebJun 28, 2024 · According to results from two clinical trials published in The New England Journal of Medicine, the addition of the chemotherapy agent cisplatin (Platinol®) to radiation improves survival compared to radiation therapy alone in the treatment of locally advanced head and neck cancer.. Approximately 40,000 people in the United States are … WebFeb 2, 2024 · The benefit of adding concomitant high-dose cisplatin to adjuvant radiotherapy (RT) for resected head and neck squamous cell carcinoma (HNSCC) was …
WebMay 26, 2004 · A Phase II Trial of Concomitant Boost Radiation and Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Study Start Date : April 2000: ... Cheng JD, … WebJan 1, 2003 · Purpose: The Head and Neck Intergroup conducted a phase III randomized trial to test the benefit of adding chemotherapy to radiation in patients with unresectable squamous cell head and neck cancer.
WebMay 18, 2024 · After the initial surgeries in the mouth and neck, happy to say after 35 radiation treatments and 3 rounds of Cisplatin, I am done with treatment for my cancer that started on my tongue and spread to my lymph nodes in my neck. I am grateful that everything went well and as expected.
WebLocally advanced squamous cell carcinoma of the head and neck: Approaches combining chemotherapy and radiation therapy … trial, weekly cisplatin as part of definitive … ireland 1930WebMay 1, 2024 · Abstract Background: Concurrent chemoradiotherapy is an established component of the nonoperative management of locally advanced head and neck squamous cell carcinoma (HNSCC), but the standard dose of 100 mg/m2 cisplatin every 3 weeks is associated with clinically significant toxicity. ireland 1936WebApr 11, 2024 · Efficacy of ketamine mouthwash in the management of oral and pharyngeal toxicity associated with head and neck chemoradiotherapy: protocol for a phase II, Simon's two-stage trial ... Patients have pathologically confirmed HNC and an intended regimen of 70 Gy of radiation with concurrent cisplatin. The protocol is initiated on diagnosis of grade ... ireland 1937WebChemotherapy consisted primarily of cisplatin and 5-FU at two dose levels in our institution. 25 One comprised cisplatin 12 mg/m 2 plus 5-FU 600 mg/m 2 per day administered as … ireland 1935WebBackground. Phase 2 studies suggest that the standard regimen of cisplatin and fluorouracil (PF) plus docetaxel (TPF) improves outcomes in squamous-cell carcinoma of … ireland 1950WebMar 30, 2024 · We performed a single-institution retrospective cohort study on adults with head and neck cancer treated with cisplatin and radiation therapy who participated in an ototoxicity monitoring program. The primary outcomes were rates of post-treatment audiograms at the following time points: one, three, six, 12, and greater than 12 months. order in n out pickupWebThese resources are referenced and utilized in an ongoing clinical trial (NCT: 03258554: Radiation Therapy With Durvalumab or Cetuximab in Treating Patients with Stage III–IVB Head and Neck Cancer Who Cannot Take Cisplatin), which investigates the efficacy of … ireland 1940